Cargando…
A Proteomics-Based Analysis Reveals Predictive Biological Patterns in Fabry Disease
Background: Fabry disease (FD) is an X-linked progressive lysosomal disease (LD) due to glycosphingolipid metabolism impairment. Currently, plasmatic globotriaosylsphingosine (LysoGb3) is used for disease diagnosis and monitoring. However, this biomarker is inconstantly increased in mild forms and i...
Autores principales: | Tebani, Abdellah, Mauhin, Wladimir, Abily-Donval, Lenaig, Lesueur, Céline, Berger, Marc G., Nadjar, Yann, Berger, Juliette, Benveniste, Oliver, Lamari, Foudil, Laforêt, Pascal, Noel, Esther, Marret, Stéphane, Lidove, Olivier, Bekri, Soumeya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7290805/ https://www.ncbi.nlm.nih.gov/pubmed/32370284 http://dx.doi.org/10.3390/jcm9051325 |
Ejemplares similares
-
Sphingosine-1-Phosphate Levels Are Higher in Male Patients with Non-Classic Fabry Disease
por: Mauhin, Wladimir, et al.
Publicado: (2022) -
Clinical Metabolomics: The New Metabolic Window for Inborn Errors of Metabolism Investigations in the Post-Genomic Era
por: Tebani, Abdellah, et al.
Publicado: (2016) -
Parsing Fabry Disease Metabolic Plasticity Using Metabolomics
por: Ducatez, Franklin, et al.
Publicado: (2021) -
Heterogenous Clinical Landscape in a Consanguineous Malonic Aciduria Family
por: Snanoudj, Sarah, et al.
Publicado: (2021) -
Clinical and Molecular Characterization of Patients with Mucopolysaccharidosis Type I in an Algerian Series
por: Tebani, Abdellah, et al.
Publicado: (2016)